FR2861079B1 - Utilisation de cations metalliques divalents pour l'amelioration de l'activite fonctionnelle des anticorps. - Google Patents

Utilisation de cations metalliques divalents pour l'amelioration de l'activite fonctionnelle des anticorps.

Info

Publication number
FR2861079B1
FR2861079B1 FR0312228A FR0312228A FR2861079B1 FR 2861079 B1 FR2861079 B1 FR 2861079B1 FR 0312228 A FR0312228 A FR 0312228A FR 0312228 A FR0312228 A FR 0312228A FR 2861079 B1 FR2861079 B1 FR 2861079B1
Authority
FR
France
Prior art keywords
antibodies
enhancing
divalent metal
metal cations
functional activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0312228A
Other languages
English (en)
Other versions
FR2861079A1 (fr
Inventor
Dominique Bourel
Arnaud Glacet
Sylvie Jorieux
Enrico Stura
Frederic Ducancel
Jean Luc Teillaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LFB SA
Original Assignee
LFB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0312228A priority Critical patent/FR2861079B1/fr
Application filed by LFB SA filed Critical LFB SA
Priority to AU2004283925A priority patent/AU2004283925A1/en
Priority to JP2006536121A priority patent/JP2007537990A/ja
Priority to CA002542928A priority patent/CA2542928A1/fr
Priority to BRPI0415620-0A priority patent/BRPI0415620A/pt
Priority to EP04805251A priority patent/EP1689785A2/fr
Priority to PCT/FR2004/002687 priority patent/WO2005040216A2/fr
Publication of FR2861079A1 publication Critical patent/FR2861079A1/fr
Priority to IL175026A priority patent/IL175026A0/en
Application granted granted Critical
Publication of FR2861079B1 publication Critical patent/FR2861079B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
FR0312228A 2003-10-20 2003-10-20 Utilisation de cations metalliques divalents pour l'amelioration de l'activite fonctionnelle des anticorps. Expired - Fee Related FR2861079B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0312228A FR2861079B1 (fr) 2003-10-20 2003-10-20 Utilisation de cations metalliques divalents pour l'amelioration de l'activite fonctionnelle des anticorps.
JP2006536121A JP2007537990A (ja) 2003-10-20 2004-10-20 抗体の機能活性を改善するための金属陽イオンの使用
CA002542928A CA2542928A1 (fr) 2003-10-20 2004-10-20 Utilisation de cations metalliques pour cristalliser le fragment fc d'un anticorps rhesus d
BRPI0415620-0A BRPI0415620A (pt) 2003-10-20 2004-10-20 uso de cátions metálicos para melhorar a atividade funcional de anticorpos
AU2004283925A AU2004283925A1 (en) 2003-10-20 2004-10-20 Use of metallic cations to improve functional activity of antibodies
EP04805251A EP1689785A2 (fr) 2003-10-20 2004-10-20 Utilisation de cations metalliques pour cristalliser le fragment fc d'un anticorps anti rhésus d
PCT/FR2004/002687 WO2005040216A2 (fr) 2003-10-20 2004-10-20 Utilisation de cations metalliques pour cristalliser le fragment fc d’un anticorps rhesus d
IL175026A IL175026A0 (en) 2003-10-20 2006-04-20 Use of metallic cations to improve functional activity of antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0312228A FR2861079B1 (fr) 2003-10-20 2003-10-20 Utilisation de cations metalliques divalents pour l'amelioration de l'activite fonctionnelle des anticorps.

Publications (2)

Publication Number Publication Date
FR2861079A1 FR2861079A1 (fr) 2005-04-22
FR2861079B1 true FR2861079B1 (fr) 2007-09-28

Family

ID=34385293

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0312228A Expired - Fee Related FR2861079B1 (fr) 2003-10-20 2003-10-20 Utilisation de cations metalliques divalents pour l'amelioration de l'activite fonctionnelle des anticorps.

Country Status (8)

Country Link
EP (1) EP1689785A2 (fr)
JP (1) JP2007537990A (fr)
AU (1) AU2004283925A1 (fr)
BR (1) BRPI0415620A (fr)
CA (1) CA2542928A1 (fr)
FR (1) FR2861079B1 (fr)
IL (1) IL175026A0 (fr)
WO (1) WO2005040216A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894982A1 (fr) * 2005-12-16 2007-06-22 Lab Francais Du Fractionnement Procede de preparation d'anticorps selectifs des recepteurs fc activateurs
FR2942799B1 (fr) * 2009-03-06 2011-02-25 Lfb Biotechnologies Anticorps monoclonal anti-rhesus d
EP2787006B1 (fr) * 2013-04-02 2018-02-28 Miltenyi Biotec GmbH Anticorps anti-CD8 dont la liaison dépend de Ca2+

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05507089A (ja) * 1990-05-08 1993-10-14 ザ スクリップス リサーチ インスティテュート 金属結合蛋白質
US5898067A (en) * 1997-02-07 1999-04-27 Novo Nordisk A/S Crystallization of proteins
FR2807767B1 (fr) * 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
FR2894982A1 (fr) * 2005-12-16 2007-06-22 Lab Francais Du Fractionnement Procede de preparation d'anticorps selectifs des recepteurs fc activateurs

Also Published As

Publication number Publication date
FR2861079A1 (fr) 2005-04-22
EP1689785A2 (fr) 2006-08-16
WO2005040216A3 (fr) 2005-10-20
IL175026A0 (en) 2006-08-20
CA2542928A1 (fr) 2005-05-06
BRPI0415620A (pt) 2006-12-12
JP2007537990A (ja) 2007-12-27
WO2005040216A2 (fr) 2005-05-06
AU2004283925A1 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
FR2890310B1 (fr) Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
FR2820050B3 (fr) Toupie pour jouer
BR0216099B1 (pt) "conjunto de desgaste".
ID23358A (id) Gsp berbantuan tanpa kawat dengan menggunakan lokasi rujukan
MA25996A1 (fr) Inhibiteurs de phosphodiesterase 4.
ATE512594T1 (de) Verbesserung des zustandes älterer haustiere
BR0201972B1 (pt) montante de suspensão.
FR22C1033I1 (fr) Utilisation de dihydroimidazolones pour le traitement des chiens
DE60025703D1 (de) Ferritische rostfreie stahlplatte
DE60200527D1 (de) Abnehmbare Mittelkonsole
FR2813756B1 (fr) Dilueur pour la conservation de spermatozoides de porcins
DE50006628D1 (de) Ultraschall-wandler
DE60124296D1 (de) Biphenylcarbonsäureamide, die sich als lipidsenker eignen
DE60003221D1 (de) Gusseisenlegierung
ATE303386T1 (de) Das citrat-salz des 5,8,14,- triazatetracyclo(10.3.1.02,11.04,9)-hexadeca- 2(11),3,5,7,9-pentaens
DE60015536D1 (de) Flüssige herbizidzusammensetzung
FR2861079B1 (fr) Utilisation de cations metalliques divalents pour l'amelioration de l'activite fonctionnelle des anticorps.
NO20021664L (no) Hydrodynamisk omvandler
FR2818287B1 (fr) Support solide pour l'immobilisation d'oligonucleotides
FR2821398B1 (fr) Disque d'embrayage
NO20010904D0 (no) Korrosjonsinhibitor
BR8103051Y1 (pt) bicicleta infantil.
FR2862113B1 (fr) Accouplement du type embrayage, notamment pour l'entrainement d'outils agricoles
ITTO20000210A0 (it) Dispositivo per favorire l'unificazione costruttiva di cartucce per apparecchi idraulici.
ATE413461T1 (de) Erhöhung des vitamin-e-gehalts in organismen durch erhöhung der tyrosinaminotransferase- aktivität

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20120629